Watchlist Price Alert

Shanghai Pharmaceuticals ... (SHPMY)

PNK: SHPMY · Real-Time Price · USD

7.09

0.09 (1.29%)

At close: May 27, 2025, 8:00 PM

Shanghai Pharmaceuticals Ltd Balance Sheet Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	35.74B	30.52B	27.4B	22.39B	22.3B	18.15B	18.69B	14.84B	11.97B
Short-Term Investments	8.63B	10.15B	9.61B	-1.24B	-1.23B	-1.36B	-1.43B	642.58K	4.06M
Long-Term Investments	1.2B	11.15B	1.86B	11.78B	8.89B	6.8B	6.08B	4.8B	4.49B
Other Long-Term Assets	10.54B	643.09M	11.12B	856.9M	392.5M	3.27B	657.08M	2.33B	2.34B
Receivables	85.32B	77.16B	70.19B	61.01B	55.52B	49.8B	43.97B	32.49B	28.88B
Inventory	38.94B	36.62B	34.46B	27.1B	24.09B	24.88B	25.02B	17.27B	16.42B
Other Current Assets	1.23B	7.98B	7.85B	5.99B	5.6B	5.21B	4.93B	4.04B	2.95B
Total Current Assets	171.82B	162.43B	149.51B	116.49B	107.56B	98.09B	93.28B	68.64B	60.27B
Property-Plant & Equipment	19.04B	18.28B	16.19B	15.39B	14.22B	12.72B	10.19B	8.69B	6.56B
Goodwill & Intangibles	16.98B	17.75B	17.92B	17.55B	16.76B	14.93B	15.63B	9.31B	8.62B
Total Long-Term Assets	49.39B	49.54B	48.62B	46.94B	41.62B	38.93B	33.6B	25.7B	22.48B
Total Assets	221.21B	211.97B	198.13B	163.44B	149.19B	137.03B	126.88B	94.34B	82.74B
Account Payables	59.48B	27.77B	51.57B	42B	37.79B	25B	35.15B	27.3B	21.24B
Deferred Revenue	n/a	n/a	2.24B	17.5B	16.21B	12.22B	1.04B	7.5B	4.74B
Short-Term Debt	38.06B	35.56B	27.75B	23.1B	29.11B	24.33B	19.42B	13.75B	9.65B
Other Current Liabilities	8.63B	27.45B	29.13B	24.03B	18.69B	10.82B	13.1B	1.09B	4.11B
Total Current Liabilities	126.04B	122.37B	110.69B	91.82B	88.13B	74.61B	68.71B	49.63B	41.11B
Long-Term Debt	8.33B	5.79B	6.26B	7.47B	1.18B	9.13B	9.62B	2.96B	2.84B
Other Long-Term Liabilities	333.6M	289.03M	-170.57M	289.94M	570.39M	654.64M	1.13B	264.91M	184.33M
Total Long-Term Liabilities	11.43B	9.27B	9.44B	12.54B	6.31B	13.03B	11.74B	5.04B	4.79B
Total Liabilities	137.47B	131.65B	120.13B	104.37B	94.44B	87.64B	80.45B	54.67B	45.91B
Total Debt	47.79B	42.9B	38.56B	31.69B	31.79B	34.62B	31.66B	16.76B	12.48B
Common Stock	3.71B	3.7B	3.7B	2.84B	2.84B	2.84B	2.84B	2.69B	2.69B
Retained Earnings	36.55B	33.82B	32.48B	28.6B	25.05B	21.97B	19.33B	16.58B	14.14B
Comprehensive Income	n/a	n/a	1.55B	1.57B	1.15B	531.08M	440.9M	664.27M	672M
Shareholders Equity	71.68B	68.52B	67.06B	49.36B	45.35B	41.66B	39.01B	34.03B	31.62B
Total Investments	9.84B	22.34B	11.48B	10.54B	7.66B	5.43B	4.65B	4.8B	4.5B